Oncotarget

Research Papers:

Synergistic neuroprotective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats

Hang Xu, WenXing Liu, TianLong Liu, Ning Su, Chao Guo, XiaoNa Feng, Fang Dou, Yi Ding _, Lei Shi and AiDong Wen

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:115434-115443. https://doi.org/10.18632/oncotarget.23272

Metrics: PDF 716 views  |   HTML 1665 views  |   ?  


Abstract

Hang Xu1,*, WenXing Liu1,*, TianLong Liu1,*, Ning Su2, Chao Guo1, XiaoNa Feng1, Fang Dou1, Yi Ding1,3, Lei Shi3 and AiDong Wen1

1Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi’an 710032, China

2Department of Radiation Oncology, Xijing Hospital, The Fourth Military Medical University, Xi’an 710032, China

3Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, China

*These authors contributed equally to this work

Correspondence to:

Yi Ding, email: dingyi.007@163.com

Lei Shi, email: lucyshi622._921@163.com

AiDong Wen, email: adwen-2004@hotmail.com

Keywords: Danshensu; hydroxysafflor yellow A; synergistic effect; neuroprotective effect; ischemic stroke

Received: October 30, 2017    Accepted: December 05, 2017    Published: December 15, 2017

ABSTRACT

Ischemic stroke is a common cerebrovascular disease with substantial morbidity and mortality worldwide. However, therapeutic options to minimize the cerebral ischemia-reperfusion (I/R) injury are limited. In China, combination of herb Danshen (Salvia miltiorrhiza Bge) and Honghua (Carthamus tinctorius L.) is effective for stroke treatment in patients but its underlying mechanism requires further investigation. Our study was conducted to evaluate and explore the synergistic effects of two herb ingredients Danshensu and hydroxysafflor yellow A (HSYA) on cerebral ischemia-reperfusion (I/R) injury in rats. Rats were randomly assigned to the following five groups: sham group, model group, Danshensu group, HSYA group, and Danshensu+HSYA group. Under our experimental conditions in vitro, oxygen-glucose deprivation (OGD) model was established to determine the synergistic neuroprotective effects of Danshensu and HSYA. With such methods as neurological deficits scoring, TTC, HE and TUNEL staining, and ELISA detection, the results demonstrated that administration of either Danshensu or HSYA improved neurological defects and alleviated pro-inflammatory and oxidative stress reactions. Notably, combination of Danshensu and HSYA exerted more effective results than that used alone. Furthermore, western blot analysis results showed that Danshensu and HSYA combination displayed synergistic regulation on TLR4/NF-κB and Nrf2/HO-1 pathways. Consistently, Danshensu +HSYA group exhibits better neuroprotection in primary neurons with OGD model compared with Danshensu or HSYA group. Taken together, we found for the first time that Danshensu plus HSYA could achieve remarkable synergistic neuroprotective effects on I/R injury, which is related to the anti-inflammatory and antioxidant pathways.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23272